We are rapidly becoming an aging society, with the ongoing increase in challenges of the elderly. The age-related cognitive decline in accordance with aging society is of major importance in public health. Recent studies have proved the impacts of sexsteroid hormone on the brain; compliant with aging, menopause and decrease in estrogen have an effect on the occurrence and prevention of Alzheimer's disease. A new hypothesis states that Alzheimer's disease is a postmenopausal dementia, and is a negative form of estrogen deficiency. In this review article, we reckoned the cause of postmenopausal Alzheimer's disease. We further investigated new cell therapies for postmenopausal Alzheimer's disease, which are under development in some pharmaceutical companies. One remedy is cell therapy that inhibits the amyloid beta formation, and the other is the umbilical cord blood derived mesenchymal stem cell therapy. 
Introduction
The population of Republic of Korea is aging at an unprecedented fast rate. And per capita medical utilization due to geriatric illness has increased since 2002 in accordance with an aging society. Among geriatric diseases in women, there are some diseases related to menopause in this aging society. 1 Average menopause age and average life expectancy is 49.7 and 85.5, respectively in Korean women, which means that they almost suffer from postmenopausal symptoms for two-fifth of their lives. The postmenopausal period in women has increased in accordance with increase in average life expectancy. Therefore, healthcare and management for postmenopausal women has become important issues recently. 2 Incidence of Alzheimer' s disease, one of postmenopausal diseases, rapidly increases after 65 years old in women, which is 1.5 to 3 times higher than men' s incidence. And cognitive function is decreased more when bone loss is occurred fast, which implies that there is a strong relevance between endogenous estrogen and Alzheimer' s disease. 3 When adipocyte stem cells are administrated intravenously to animal models with Alzheimer' s disease, it pass through blood-brain-barrier (BBB) and move into brain.
Consequently, positive neuropathological effects such as improvement in scholastic skills, memory were shown.
In this mechanism, up-regulated interleukin-10 and neurotrophic factors, which both are neuroprotective, were shown. 8 Also, level of amyloid beta and C-protein that destroying brain cells were significantly decreased due to 
